Supported Studies

We work closely with our partners to fund lab research of rare and underfunded pediatric cancers. We also support clinical research in local hospitals through the work of the Children's Oncology Group.

Research studies that we have funded in 2018:

The Crazy 8 Initiative
Multiple Institutions
Multinational initiative with the purpose of detailing roadmaps for cures for specific, hard-to-treat childhood cancers and pressing topics of the childhood cancer community.
Funding Partner: Alex‘s Lemonade Stand Foundation

Dana-Farber Cancer Institute
Boston, MA
Mark Zimmerman, PhD
MYC-driven core regulatory circuits in neuroblastoma
Funding Partner: Alex‘s Lemonade Stand Foundation

Massachusetts General Hospital
Boston, MA
Chuan Yan, PhD
Accessing combinatorial effect of PARP inhibitor with DNA damaging agent in rhabdomyosarcoma at single cell resolution
Funding Partner: Alex‘s Lemonade Stand Foundation

The Johns Hopkins University School of Medicine
Baltimore, MD
Eric H Raabe, MD/PhD
Identifying a therapeutic partner for TAK228 for pediatric phase II brain tumor studies
Funding Partner: Alex‘s Lemonade Stand Foundation

University of Texas Southwestern Medical Center
Dallas, TX
Genevieve Kendall, PhD
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma
Funding Partner: Alex‘s Lemonade Stand Foundation

University of Texas Health Science Center at San Antonio
San Antonio, TX
Patricia Dahia, MD/PhD
RNA methylation in metabolically disrupted pediatric cancers
Funding Partner: Alex‘s Lemonade Stand Foundation

Children‘s Hospital Los Angeles
Los Angeles, CA
David Cobrinik, MD/PhD
Circulating repetitive element RNAs as an osteosarcoma marker
Funding Partner: Alex‘s Lemonade Stand Foundation

The Children‘s Hospital of Philadelphia
Philadelphia, PA
Jo Lynne Harenza
Defining the subclonal landscape of high-risk neuroblastoma
Funding Partner: Bear Necessities Pediatric Cancer Foundation

Dana Farber Cancer Institute
Boston, MA
Kimberly Stegmier
New metabolic targets in Acute Lymphoblastic Leukemia (ALL)
Funding Partner: Bear Necessities Pediatric Cancer Foundation

The Children‘s Oncology Group
Nationwide
Peter Adamson, COG Chair
Project Everychild
Funding Partner: Bear Necessities Pediatric Cancer Foundation

Cleveland Clinic Children‘s Hospital
Cleveland, OH
Stacey Zahler
Defining Markers of Radiosensitivity: Radiogenomic Profiiling of Rhabdomyosarcoma
Funding Partner: Cleveland Clinic

The Washington University, Children‘s Hospital of Philadelphia, UCSF, DKFZ (Germany)
Multiple Institutions
David Gutmann, Michael Fisher, Bill Weiss, Stefan Pfister, David Jones, Joanna Phillips, Adam Resnik, Angela Waanders
Identification, functional characterization and therapeutic exploitation of the integrated landscape of genetic and epigenetic alterations in glioma from patients with NF1
Funding Partner: Children‘s Tumor Foundation

Columbia University
New York, NY
Antonio Iavarone
Identification, functional characterization and therapeutic exploitation of the integrated landscape of genetic and epigenetic alterations in glioma from patients with NF1
Funding Partner: Children's Tumor Foundation

Buy a Puravida Bracelet and show your LOVE to children with cancer more

This authentic Puravida Bracelet gives twice the smiles. For every bracelet you purchase for $10, we will give a Puravida bracelet to a child with cancer.

Spread the wordgo

Send a personal appeal to your friends and family.

FORM